• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

Everything we know about the Johnson & Johnson COVID vaccine pause (so far)

By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
By
Chris Morris
Chris Morris
Former Contributing Writer
Down Arrow Button Icon
April 13, 2021, 12:58 PM ET

Tuesday’s surprise recommendation that health care providers pause the use of Johnson & Johnson’s COVID-19 vaccine left a lot of people scrambling. While the one-and-done shot has not been as widespread, in terms of distribution, as those by Moderna and Pfizer, nearly 7 million people already have received it.

The Food and Drug Administration and Centers for Disease Control and Prevention, which issued the guidance, are just beginning their investigations into the reports of potentially dangerous blood clots that occurred in six women in the days after vaccination. Both say the action was taken “out of an abundance of caution,” but that doesn’t answer a lot of questions. Here’s what the agencies have to say about some specific concerns.

I got the J&J vaccine a month (or more) ago. Should I be worried?

Health officials say the risk is very low to people who had the J&J vaccine more than a month ago. Any issues with clotting likely would have presented by now.

I just got a J&J vaccine shot recently. What should I be on alert for?

Again, the odds of developing the clots are low. But CDC Principal Deputy Director Anne Schuchat is suggesting people look for symptoms including severe headache, abdominal pain, leg pain, and shortness of breath. If you develop these within three weeks of getting your J&J shot, contact your health care provider and seek treatment.

She notes, though, that the flu-like symptoms that occur after receiving the vaccine are not things to worry about.

How long will this pause last?

That’s not known precisely right now, but Janet Woodcock, acting FDA commissioner, says “we expect it to be a matter of days.” The CDC says it’s committing to an expeditious review of the available information and an aggressive outreach to physicians so they’ll know how to diagnose, treat, and report issues.

Does this mean I can’t get the J&J COVID vaccine at all now?

No, but it’s probably better to wait. The recommendation is not a mandate, says Dr. Peter Marks, director of the FDA’s center for biologics evaluation and research. “If an individual health care provider has talked with a patient and they determine that the benefit/risk for that patient is appropriate, we’re not going to stop that provider from administering the vaccine.”

That said, expect most mass vaccination sites and pharmacies to follow the advice of the FDA and CDC for now.

I was supposed to get vaccinated this week. What do I do now?

If you have an appointment this week to get the J&J shot, check with your health care provider. Some are already shifting people over to Pfizer or Moderna. Others will reschedule you for another day in the near future, when a Pfizer or Moderna shot is available.

Important: If you have an J&J appt at a NY State-run vax site today (e.g. Javits, Aqueduct), you should still go and you will be offered Pfizer instead.

— Mark D. Levine (@MarkLevineNYC) April 13, 2021

“This may be a bit bumpy,” Schuchat says. “But we do want to make sure people who are scheduled to get vaccinations will be able to get [one] when vaccines are available.”

Are the clots associated with the J&J vaccine fatal?

Of the six cases that have been reported so far, one was fatal and one patient is in critical condition, officials say.

Should I be worried about blood clots with the Moderna or Pfizer vaccine?

The FDA and CDC say there have been no reports of any clotting issues with the other two vaccines being distributed in the U.S. right now. And, to date, there have been over 180 million injections of those, which should allay fears of a similar reaction.

Why did the pause of J&J’s vaccine seemingly come with no warning?

Even the FDA admits this was a sudden action. It comes down to transparency and wanting to prevent possible additional cases.

“I wish we had more time to get everyone prepared and this could have gone even more smoothly,” Woodcock says. “As we learned about the issue…it was clear to us that we needed to alert the public…The decision was based on events that might occur between when we made that realization and when we got the word out.”

What about the European rollout of J&J’s vaccine?

Johnson & Johnson announced Tuesday that it would be proactively delaying the rollout of the vaccine in Europe and would review the cases with European health authorities.

About the Author
By Chris MorrisFormer Contributing Writer

Chris Morris is a former contributing writer at Fortune, covering everything from general business news to the video game and theme park industries.

See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Successthe future of work
As boomer and Gen X bosses retire, working from home will make a major comeback, new research predicts—and it’s all thanks to work-life balance loving Gen Z bosses
By Orianna Rosa RoyleFebruary 17, 2026
7 hours ago
HealthHealth
Confronting Asia’s growing rate of chronic conditions means tackling cultural issues as much as medical ones
By Stuart A. SpencerFebruary 15, 2026
2 days ago
Susan Blumenthal
AICancer
Meet the American spies who helped mammograms save more lives
By Erik GermanFebruary 15, 2026
2 days ago
HealthDietary Supplements
5 Best Nootropics of 2026: Expert Reviewed Supplements
By Christina SnyderFebruary 13, 2026
4 days ago
Big TechGen Z
Analog-obsessed Gen Zers are buying $40 app blockers to limit their social media use and take a break from the ‘slot machine in your pocket’
By Marco Quiroz-GutierrezFebruary 13, 2026
4 days ago
Leesa Sapira Chill
Healthmattresses
Presidents Day Mattress Sales 2026: Find Deals on the Best Sleep Brands
By Christina SnyderFebruary 13, 2026
4 days ago

Most Popular

placeholder alt text
Economy
Social Security's trust fund is nearing insolvency, and the borrowing binge that may follow will rip through debt markets, economist warns
By Jason MaFebruary 15, 2026
2 days ago
placeholder alt text
Real Estate
A billionaire and an A-list actor found refuge in a 37-home Florida neighborhood with armed guards—proof that privacy is now the ultimate luxury
By Marco Quiroz-GutierrezFebruary 15, 2026
2 days ago
placeholder alt text
Future of Work
Malcolm Gladwell tells young people if they want a STEM degree, 'don’t go to Harvard.' You may end up at the bottom of your class and drop out
By Sasha RogelbergFebruary 14, 2026
3 days ago
placeholder alt text
Investing
Trillion-dollar AI market wipeout happened because investors banked that 'almost every tech company would come out a winner'
By Eleanor PringleFebruary 16, 2026
1 day ago
placeholder alt text
Commentary
Something big is happening in AI — and most people will be blindsided
By Matt ShumerFebruary 11, 2026
6 days ago
placeholder alt text
C-Suite
Blackstone mogul warned of 'urgent need' for AI preparedness—now he’s turning his $48 billion fortune into a top philanthropic foundation
By Sydney LakeFebruary 16, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.